Acta Neuropathologica Communications · 2020 · 20 citations · 42 references
Life SciencesNeurologyNeuroscienceMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersProtein AggregationProtein Aggregation DisordersTau PathologyDoxycycline TreatmentNeurodegenerative CascadeProtein AggregatesRegional CorrelationTau HyperphosphorylationTau OligomerizationTauopathy Models
Neurodegenerative diseases are characterized by the accumulation of specific phosphorylated protein aggregates in the brain, such as hyperphosphorylated tau (hp-tau) in tauopathies and phosphorylated α-synuclein (p-αSyn) in α-synucleinopathies. The simultaneous accumulation of different proteins is a common event in many neurodegenerative diseases. We herein describe the detection of the phosphorylation and dimerization of αSyn and activation of GSK-3β, a major kinase known to phosphorylate tau and αSyn, in the brains of rTg4510 mice that overexpress human P301L mutant tau. Immunohistochemistry showed p-αSyn aggregates in rTg4510 mice, which were suppressed by doxycycline-mediated decreases in mutant tau expression levels. A semi-quantitative analysis revealed a regional correlation between hp-tau and p-αSyn accumulation in rTg4510 mice. Furthermore, proteinase K-resistant αSyn aggregates were found in the region with excessive hp-tau accumulation in rTg4510 mice, and these aggregates were morphologically different from proteinase K-susceptible p-αSyn aggregates. Western blotting revealed decreases in p-αSyn monomers in TBS- and sarkosyl-soluble fractions and increases in ubiquitinated p-αSyn dimers in sarkosyl-soluble and insoluble fractions in rTg4510 mice. Furthermore, an activated form of GSK-3β was immunohistochemically detected within cells containing both hp-tau and p-αSyn aggregates. A semi-quantitative analysis revealed that increased GSK-3β activity strongly correlated with hp-tau and p-αSyn accumulation in rTg4510 mice. Collectively, the present results suggest that the overexpression of human P301L mutant tau promoted the phosphorylation and dimerization of endogenous αSyn by activating GSK-3β in rTg4510 mice. This synergic effect between tau, αSyn, and GSK-3β may be involved in the pathophysiology of several neurodegenerative diseases that show the accumulation of both tau and αSyn.
42
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
Karen S. SantaCruz, Jada Lewis, Jennifer Paulson et al. · Science · 2005 · 2K citations · Full text
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Nunilo Cremades, Samuel I. A. Cohen, Emma Deas et al. · Cell · 2012 · 902 citations · Full text
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda‐Suzukake, Takashi Nonaka, Masato Hosokawa et al. · Brain · 2013 · 888 citations · Full text